Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $539.48 million as of January 22, 2025. Its market cap has increased by 270.41% in one year.

Market Cap

539.48M

Enterprise Value

541.32M

Revenue

71.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.51

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 539.48M, an increase of 5,534.10%. That is a compound annual growth rate of 16.42%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	539.48M	-6.67%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.99B
Veradigm	1.54B
SS Innovations International	1.46B
Nika Pharmaceuticals	603.98M
Glass House Brands	431.12M
Northwest Biotherapeutics	367.83M
BioStem Technologies	264.80M
Silence Therapeutics	241.74M

Market Cap Rankings